Literature DB >> 21470958

In vitro study and biocompatibility of calcined mesoporous silica microparticles in mouse lung.

Suhail Al-Salam1, Ghazala Balhaj, Suleiman Al-Hammadi, Manjusha Sudhadevi, Saeed Tariq, Ankush V Biradar, Tewodros Asefa, Abdul-Kader Souid.   

Abstract

We report on the pneumatocyte structure and function of mouse lung specimens exposed in vitro to two calcined mesoporous silica particles, MCM41-cal (spheres, ∼300 to 1000 nm in diameter) and SBA15-cal (irregular rods averaging ∼500 nm in diameter and ∼1000 nm in length). These mesoporous silica particles are in consideration for potential medical application as delivery vehicles for genes, drugs, and bio-imagers. In the study, lung specimens (about 10 mg each) were excised from male Balb/c mice, immediately immersed in Krebs-Henseleit buffer, ice-cold, and continuously gassed with O(2):CO(2) (95:5). The samples were incubated at 37°C in the same buffer with and without 200 μg/mL MCM41-cal or SBA15-cal for 5-14 h. The tissues were then rinsed thoroughly and processed for light and electron microscopy. Normal alveolar morphology was evident in all the studied specimens. There was no significant difference in the number of apoptotic cells between the treated and untreated samples. Despite their relatively large sizes, the particles were abundantly present in pneumocytes, macrophages, endothelial cells, fibroblasts, and interstitium. They were seen in different areas of the cytoplasm, suggesting intracellular movements. Their presence did not appear to disturb cellular configuration or micro-organelles. Due to their rigidity and surface charges, some were firmly attached to (indenting) the nuclear membrane. The rate of respiration (cellular mitochondrial O(2) consumption, in μM O(2)/min/mg) in specimens exposed to 200 μg/mL particles for up to 12 h was the same as untreated specimens. These findings confirm "reasonable" bioavailability and biocompatibility of calcined mesoporous silicas with mouse lung within at least 5-14 h of exposure time.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21470958     DOI: 10.1093/toxsci/kfr078

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  7 in total

Review 1.  Biocompatibility assessment of Si-based nano- and micro-particles.

Authors:  Hamsa Jaganathan; Biana Godin
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

2.  The cytotoxicity of aflatoxin b1 in human lymphocytes.

Authors:  Suleiman Al-Hammadi; Farida Marzouqi; Aysha Al-Mansouri; Allen Shahin; Mariam Al-Shamsi; Eric Mensah-Brown; Abdul-Kader Souid
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27

3.  Preparation of iron oxide mesoporous magnetic microparticles as novel multidrug carriers for synergistic anticancer therapy and deep tumor penetration.

Authors:  Kheireddine El-Boubbou; Rizwan Ali; Hajar Al-Zahrani; Thadeo Trivilegio; Abdullah H Alanazi; Abdul Latif Khan; Mohamed Boudjelal; Abdulmohsen AlKushi
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

4.  In vitro biocompatibility of calcined mesoporous silica particles and fetal blood cells.

Authors:  Mohammed T Al Samri; Ankush V Biradar; Ahmed R Alsuwaidi; Ghazala Balhaj; Suleiman Al-Hammadi; Safa Shehab; Suhail Al-Salam; Saeed Tariq; Thachillath Pramathan; Sheela Benedict; Tewodros Asefa; Abdul-Kader Souid
Journal:  Int J Nanomedicine       Date:  2012-08-03

5.  Lung tissue bioenergetics and caspase activity in rodents.

Authors:  Ahmed R Alsuwaidi; Mohammed T Alsamri; Ali S Alfazari; Saeeda Almarzooqi; Alia Albawardi; Aws R Othman; Thachillath Pramathan; Stacey M Hartwig; Steven M Varga; Abdul-Kader Souid
Journal:  BMC Res Notes       Date:  2013-01-12

6.  A preparation of murine liver fragments for in vitro studies: liver preparation for toxicological studies.

Authors:  Ali S Alfazari; Bayan Al-Dabbagh; Saeeda Almarzooqi; Alia Albawardi; Abdul-Kader Souid
Journal:  BMC Res Notes       Date:  2013-02-25

7.  Bioenergetics of murine lungs infected with respiratory syncytial virus.

Authors:  Ahmed R Alsuwaidi; Sheela Benedict; Jose Kochiyil; Farah Mustafa; Stacey M Hartwig; Saeeda Almarzooqi; Alia Albawardi; Tahir A Rizvi; Steven M Varga; Abdul-Kader Souid
Journal:  Virol J       Date:  2013-01-15       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.